Status:
COMPLETED
Pediatric Reporting of Adult-Onset Genomic Results
Lead Sponsor:
Geisinger Clinic
Collaborating Sponsors:
National Human Genome Research Institute (NHGRI)
Conditions:
Hereditary Breast and Ovarian Cancer Syndrome
Lynch Syndrome
Eligibility:
All Genders
Phase:
EARLY_PHASE1
Brief Summary
The Investigators will conduct a longitudinal, mixed-methods cohort study to assess primary and secondary psychosocial outcomes among 705 MyCode pediatric participants and their parents, and health be...
Detailed Description
The Investigators propose a longitudinal, observational cohort study using mixed methods to compare change in psychosocial outcomes and health behaviors among three study groups of pediatric MyCode pa...
Eligibility Criteria
Inclusion
- Any pediatric MyCode participant (ages 0-17) OR
- Parent of a pediatric MyCode participant who has given assent to participate in this study.
Exclusion
- Individuals who have already had genetic counseling for any of the actionable target conditions as part of their routine clinical care.
- Individuals who have already had genetic counseling for any of the actionable target conditions through their participation in another research study.
Key Trial Info
Start Date :
November 25 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 31 2024
Estimated Enrollment :
427 Patients enrolled
Trial Details
Trial ID
NCT03832985
Start Date
November 25 2020
End Date
October 31 2024
Last Update
November 5 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Geisinger
Danville, Pennsylvania, United States, 17822